Financhill
Back

Y-mAbs Therapeutics Vs. Theriva Biologics Industry Stock Comparison

Sell
29

YMAB
Y-mAbs Therapeutics

Last Price:
10.01
Seasonality Move:
12.09%
Sell
34

TOVX
Theriva Biologics

Last Price:
1.15
Seasonality Move:
6.22%
Sell
29
Y-mAbs Therapeutics (YMAB) is a Sell

Is Y-mAbs Therapeutics a Buy, Sell or Hold?

  • The current Y-mAbs Therapeutics [YMAB] share price is $10.01. The Score for YMAB is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
  • YMAB is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
34
Theriva Biologics (TOVX) is a Sell

Is Theriva Biologics a Buy, Sell or Hold?

  • The current Theriva Biologics [TOVX] share price is $1.14. The Score for TOVX is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • TOVX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

YMAB Stock Price Chart

What is Y-mAbs Therapeutics's stock price today?

  • The Y-mAbs Therapeutics share price today is $10.01
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and YMAB is experiencing slight selling pressure.

TOVX Stock Price Chart

What is Theriva Biologics's stock price today?

  • The Theriva Biologics share price today is $1.14
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TOVX is experiencing selling pressure, which indicates risk of future bearish movement.

YMAB Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.84 Sell
Relative Strength Index (14 RSI): 32.47 Sell
Chaikin Money Flow: -71841 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (9.89 - 13.51) Sell
Bollinger Bands (100): (11.39 - 14.57) Sell

TOVX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.12 Sell
Relative Strength Index (14 RSI): 34.68 Sell
Chaikin Money Flow: -140529 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.16 - 1.68) Sell
Bollinger Bands (100): (1.15 - 4.67) Sell

YMAB Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 10.52 Sell
20-day SMA: 10.89 Sell
50-day SMA: 13.07 Sell
200-day SMA: 13.45 Sell
8-day EMA: 10.47 Sell
20-day EMA: 11.22 Sell
50-day EMA: 12.31 Sell
200-day EMA: 12.4 Sell

TOVX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.29 Sell
20-day SMA: 1.31 Sell
50-day SMA: 1.49 Sell
200-day SMA: 6 Sell
8-day EMA: 1.27 Sell
20-day EMA: 1.36 Sell
50-day EMA: 1.8 Sell
200-day EMA: 5.56 Sell

Y-mAbs Therapeutics Earnings Growth & YMAB Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.01 per share, and an increase next year of $0.05 per share.

Theriva Biologics Earnings Growth & TOVX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $5.00 per share, and an increase next year of $22.60 per share.

Y-mAbs Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Theriva Biologics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):